Summary:
A 6 week randomized, parallel, double blind, placebo-controlled, fixed dose, multicenter study to evaluate the efficacy and safety of Lurasidone in children and adolescent subjects with irritability associated with autistic disorder.
Qualified Participants Must:
• Be between 6 and 17 years of age
•
Currently be diagnosed with Autistic disorder
Qualified Participants May Receive:
Free medical evaluation, free study medication and compensation for time and travel.